Growing community of inventors

Boston, MA, United States of America

Denise Christine Grunenfelder

Average Co-Inventor Count = 9.47

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Denise Christine GrunenfelderRichard Eric Olson (2 patents)Denise Christine GrunenfelderUpender Velaparthi (2 patents)Denise Christine GrunenfelderJayakumar Sankara Warrier (2 patents)Denise Christine GrunenfelderPrasada Rao Jalagam (2 patents)Denise Christine GrunenfelderSaumya Roy (2 patents)Denise Christine GrunenfelderRobert G Gentles (1 patent)Denise Christine GrunenfelderMin Ding (1 patent)Denise Christine GrunenfelderScott W Martin (1 patent)Denise Christine GrunenfelderLouis Stanley Chupak (1 patent)Denise Christine GrunenfelderBireshwar Dasgupta (1 patent)Denise Christine GrunenfelderChetan Padmakar Darne (1 patent)Denise Christine GrunenfelderHasibur Rahaman (1 patent)Denise Christine GrunenfelderDenise Christine Grunenfelder (2 patents)Richard Eric OlsonRichard Eric Olson (108 patents)Upender VelaparthiUpender Velaparthi (32 patents)Jayakumar Sankara WarrierJayakumar Sankara Warrier (23 patents)Prasada Rao JalagamPrasada Rao Jalagam (13 patents)Saumya RoySaumya Roy (13 patents)Robert G GentlesRobert G Gentles (28 patents)Min DingMin Ding (28 patents)Scott W MartinScott W Martin (23 patents)Louis Stanley ChupakLouis Stanley Chupak (23 patents)Bireshwar DasguptaBireshwar Dasgupta (16 patents)Chetan Padmakar DarneChetan Padmakar Darne (14 patents)Hasibur RahamanHasibur Rahaman (11 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (1 from 832,680 patents)

2. Bristol-myers Squibb Compnay (1 from 3,681 patents)


2 patents:

1. 11964973 - Substituted bicyclic compounds useful as T cell activators

2. 11584747 - Substituted pyridopyrimidinonyl compounds useful as T cell activators

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…